1劑4900萬 SMA基因治療藥將納健保
全球最貴藥物之一「諾健生」(Zolgensma),用於治療罕見疾病脊髓肌肉萎縮症(SMA),八月將納入健保給付,經議價一...
全球最貴藥物之一「諾健生」(Zolgensma),用於治療罕見疾病脊髓肌肉萎縮症(SMA),八月將納入健保給付,經議價一...
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.